NCT06306560View on ClinicalTrials.gov

A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

March 15, 2027

Study Completion Date

April 15, 2027

Conditions
Extensive-stage Small-cell Lung Cancer
Interventions
DRUG

adebrelimab

adebrelimab IV

DRUG

famitinib

famitinib PO

DRUG

chemotherapy

chemotherapy IV

All Listed Sponsors
lead

Harbin Medical University

OTHER

NCT06306560 - A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC. | Biotech Hunter | Biotech Hunter